Corient Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $6.53M | Hold |
84,777
| – | – | 0.49% | 46 |
|
2022
Q2 | $6.53M | Buy |
84,777
+4,709
| +6% | +$363K | 0.49% | 48 |
|
2022
Q1 | $5.85M | Buy |
80,068
+7,052
| +10% | +$515K | 0.39% | 58 |
|
2021
Q4 | $4.55M | Buy |
73,016
+6,236
| +9% | +$389K | 0.3% | 83 |
|
2021
Q3 | $3.95M | Sell |
66,780
-186
| -0.3% | -$11K | 0.29% | 81 |
|
2021
Q2 | $4.48M | Sell |
66,966
-309
| -0.5% | -$20.6K | 0.33% | 72 |
|
2021
Q1 | $4.25M | Sell |
67,275
-50
| -0.1% | -$3.16K | 0.36% | 68 |
|
2020
Q4 | $4.18M | Buy |
67,325
+1,478
| +2% | +$91.7K | 0.42% | 61 |
|
2020
Q3 | $3.97M | Buy |
65,847
+2,647
| +4% | +$160K | 0.46% | 55 |
|
2020
Q2 | $3.72M | Buy |
63,200
+1,952
| +3% | +$115K | 0.45% | 55 |
|
2020
Q1 | $3.41M | Buy |
61,248
+5,509
| +10% | +$307K | 0.54% | 46 |
|
2019
Q4 | $3.58M | Buy |
55,739
+35,111
| +170% | +$2.25M | 0.45% | 53 |
|
2019
Q3 | $1.05M | Buy |
20,628
+8,738
| +73% | +$443K | 0.15% | 156 |
|
2019
Q2 | $540K | Buy |
11,890
+2,875
| +32% | +$131K | 0.08% | 225 |
|
2019
Q1 | $431K | Buy |
9,015
+127
| +1% | +$6.07K | 0.07% | 241 |
|
2018
Q4 | $462K | Buy |
8,888
+3,331
| +60% | +$173K | 0.08% | 213 |
|
2018
Q3 | $345K | Hold |
5,557
| – | – | 0.06% | 223 |
|
2018
Q2 | $307K | Buy |
5,557
+1,870
| +51% | +$103K | 0.05% | 224 |
|
2018
Q1 | $233K | Sell |
3,687
-440
| -11% | -$27.8K | 0.04% | 233 |
|
2017
Q4 | $253K | Sell |
4,127
-254
| -6% | -$15.6K | 0.04% | 257 |
|
2017
Q3 | $279K | Sell |
4,381
-666
| -13% | -$42.4K | 0.05% | 232 |
|
2017
Q2 | $281K | Sell |
5,047
-78
| -2% | -$4.34K | 0.04% | 262 |
|
2017
Q1 | $279K | Sell |
5,125
-636
| -11% | -$34.6K | 0.04% | 262 |
|
2016
Q4 | $337K | Sell |
5,761
-136
| -2% | -$7.96K | 0.06% | 242 |
|
2016
Q3 | $318K | Buy |
+5,897
| New | +$318K | 0.06% | 249 |
|